Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1990 Mar;49(3):160–162. doi: 10.1136/ard.49.3.160

Autoantibody and idiotype profile of lung involvement in autoimmune rheumatic disease.

L Turner-Stokes 1, P Haslam 1, M Jones 1, C Dudeney 1, S Le Page 1, D Isenberg 1
PMCID: PMC1004012  PMID: 2322027

Abstract

Several reports have linked the presence of certain serum autoantibodies with particular clinical manifestations of autoimmune disease. For example, the Jo-1 antibody is now established as a marker for fibrosing alveolitis in polymyositis. To investigate the possible association of further autoantibodies or idiotypes with fibrosing alveolitis in autoimmune rheumatic disease a panel of autoantibodies was measured in serum samples from 28 patients with systemic lupus erythematosus (SLE) (10 with and 18 without lung involvement), 21 patients with scleroderma (12 with fibrosing alveolitis and nine without), and 41 patients with 'lone' fibrosing alveolitis. Antibodies measured were IgM and IgG anti-dsDNA and anti-ssDNA antibody; IgG and IgM anticardiolipin antibody; anti-poly (ADP-ribose) antibody; antibodies to two common idiotypes of anti-DNA antibodies, designated 134 and 16/6; and IgM, IgG, and IgA isotypes of rheumatoid factor. None of these antibodies was specifically associated with lung involvement in SLE or scleroderma, but a trend was found towards an increase in all autoantibodies in association with lung disease in SLE, while the reverse trend was seen in scleroderma.

Full text

PDF
160

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cameron J. S., Lessof M. H., Ogg C. S., Williams B. D., Williams D. G. Disease activity in the nephritis of systemic lupus erythematosus in relation to serum complement concentrations. DNA-binding capacity and precipitating anti-DNA antibody. Clin Exp Immunol. 1976 Sep;25(3):418–427. [PMC free article] [PubMed] [Google Scholar]
  2. Chapman J. R., Charles P. J., Venables P. J., Thompson P. J., Haslam P. L., Maini R. N., Turner Warwick M. E. Definition and clinical relevance of antibodies to nuclear ribonucleoprotein and other nuclear antigens in patients with cryptogenic fibrosing alveolitis. Am Rev Respir Dis. 1984 Sep;130(3):439–443. doi: 10.1164/arrd.1984.130.3.439. [DOI] [PubMed] [Google Scholar]
  3. Dudeney C., Shoenfeld Y., Rauch J., Jones M., Mackworth Young C., Tavassoli M., Shall S., Isenberg D. A. A study of anti-poly (ADP-ribose) antibodies and an anti-DNA antibody idiotype and other immunological abnormalities in lupus family members. Ann Rheum Dis. 1986 Jun;45(6):502–507. doi: 10.1136/ard.45.6.502. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Hedgpeth M. T., Boulware D. W. Interstitial pneumonitis in antinuclear antibody-negative systemic lupus erythematosus: a new clinical manifestation and possible association with anti-Ro (SS-A) antibodies. Arthritis Rheum. 1988 Apr;31(4):545–548. doi: 10.1002/art.1780310412. [DOI] [PubMed] [Google Scholar]
  5. Isenberg D. A., Maddison P., Swana G., Skinner R. P., Swana M., Jones M., Addison I., Dudeney C., Shall S., el Roiey A. Profile of autoantibodies in the serum of patients with tuberculosis, klebsiella and other gram-negative infections. Clin Exp Immunol. 1987 Mar;67(3):516–523. [PMC free article] [PubMed] [Google Scholar]
  6. Isenberg D. A., Shoenfeld Y., Madaio M. P., Rauch J., Reichlin M., Stollar B. D., Schwartz R. S. Anti-DNA antibody idiotypes in systemic lupus erythematosus. Lancet. 1984 Aug 25;2(8400):417–422. doi: 10.1016/s0140-6736(84)92904-0. [DOI] [PubMed] [Google Scholar]
  7. Isenberg D. A., Williams W., Le Page S., Swana G., Feldman R., Addison I., Bakimer R., Shoenfeld Y. A comparison of autoantibodies and common DNA antibody idiotypes in SLE patients and their spouses. Br J Rheumatol. 1988 Dec;27(6):431–435. doi: 10.1093/rheumatology/27.6.431. [DOI] [PubMed] [Google Scholar]
  8. Maddison P. J., Isenberg D. A., Goulding N. J., Leddy J., Skinner R. P. Anti La(SSB) identifies a distinctive subgroup of systemic lupus erythematosus. Br J Rheumatol. 1988 Feb;27(1):27–31. doi: 10.1093/rheumatology/27.1.27. [DOI] [PubMed] [Google Scholar]
  9. Nishikai M., Reichlin M. Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis. Characterization of the Jo-1 antibody system. Arthritis Rheum. 1980 Aug;23(8):881–888. doi: 10.1002/art.1780230802. [DOI] [PubMed] [Google Scholar]
  10. Nordstrom D. M., West S. G., Rubin R. L. Methyldopa-induced systemic lupus erythematosus. Arthritis Rheum. 1989 Feb;32(2):205–208. doi: 10.1002/anr.1780320214. [DOI] [PubMed] [Google Scholar]
  11. Pereira S., Black C., Welsh K., Ansell B., Jayson M., Maddison P., Rowell N. Autoantibodies and immunogenetics in 30 patients with systemic sclerosis and their families. J Rheumatol. 1987 Aug;14(4):760–765. [PubMed] [Google Scholar]
  12. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Bull Rheum Dis. 1981;31(1):1–6. [PubMed] [Google Scholar]
  13. Scott J. S., Maddison P. J., Taylor P. V., Esscher E., Scott O., Skinner R. P. Connective-tissue disease, antibodies to ribonucleoprotein, and congenital heart block. N Engl J Med. 1983 Jul 28;309(4):209–212. doi: 10.1056/NEJM198307283090403. [DOI] [PubMed] [Google Scholar]
  14. Steen V. D., Powell D. L., Medsger T. A., Jr Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. Arthritis Rheum. 1988 Feb;31(2):196–203. doi: 10.1002/art.1780310207. [DOI] [PubMed] [Google Scholar]
  15. Tan E. M., Cohen A. S., Fries J. F., Masi A. T., McShane D. J., Rothfield N. F., Schaller J. G., Talal N., Winchester R. J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 Nov;25(11):1271–1277. doi: 10.1002/art.1780251101. [DOI] [PubMed] [Google Scholar]
  16. Turner-Stokes L., Turner-Warwick M. Intrathoracic manifestations of SLE. Clin Rheum Dis. 1982 Apr;8(1):229–242. [PubMed] [Google Scholar]
  17. Yoshida S., Akizuki M., Mimori T., Yamagata H., Inada S., Homma M. The precipitating antibody to an acidic nuclear protein antigen, the Jo-1, in connective tissue diseases. A marker for a subset of polymyositis with interstitial pulmonary fibrosis. Arthritis Rheum. 1983 May;26(5):604–611. doi: 10.1002/art.1780260505. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES